Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.
American Shared Hospital Services (NYSE American: AMS) regularly issues news updates that describe its role as a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services. Its press releases highlight developments across its medical equipment leasing and direct patient care services segments, giving investors and observers insight into how the company’s cancer treatment–focused operations are evolving.
News items frequently cover quarterly and annual financial results, where the company reports revenue from Gamma Knife, linear accelerator (LINAC), and proton beam radiation therapy, as well as performance in its direct patient care services segment. These releases often include management commentary on treatment volumes, contract activity, new center openings, and the balance between leasing and direct patient care services.
American Shared Hospital Services’ news flow also emphasizes business expansion and partnerships. Recent disclosures reference acquiring majority interests in radiation therapy treatment centers in Rhode Island, opening a radiation therapy center in Puebla, Mexico, and planning additional radiation therapy and proton beam centers under Certificate of Need approvals. The company’s descriptions of turnkey solutions for cancer treatment centers, health systems, and cancer networks in North and South America are a recurring theme in its announcements.
Regulatory and corporate governance updates appear in the form of conference call announcements, shareholder meeting notices, and SEC-related disclosures. These include scheduling of earnings calls, participation in investor conferences, and information about annual shareholder meetings. Together, the AMS news feed on this page provides a centralized view of the company’s reported financial performance, operational changes in its cancer treatment services, and key corporate events.
American Shared Hospital Services (AMS) will present at the 15th Annual Main Event on October 25, 2022, at 8:00 AM PT in Los Angeles. The event will showcase over 200 companies, providing a platform for corporate overviews and investor meetings. AMS specializes in advanced radiation therapy solutions, including stereotactic radiosurgery and Gamma Knife equipment for treating brain tumors. The presentation will be led by CEO Ray Stachowiak and President/CFO Craig Tagawa. Investors can register to watch the presentation live online.
American Shared Hospital Services (AMS) has appointed Peter Gaccione as Chief Operating Officer, effective September 7, 2022. Gaccione brings over 40 years of experience in Radiation Oncology, having previously led Myocardial Solutions Inc. and held executive roles at Elekta AB. His leadership is expected to strengthen AMS's management team and enhance growth opportunities in photon and proton technologies. CEO Ray Stachowiak expressed confidence in Gaccione's market knowledge and relationship-building skills, reinforcing AMS's commitment to providing comprehensive cancer treatment solutions.
American Shared Hospital Services (AMS) reported strong second-quarter results for 2022, achieving total revenue of $5,034,000, up 12.5% compared to the same period in 2021, marking the highest revenue since Q3 2019. Proton therapy revenue soared by 49%, while Gamma Knife revenue fell by 6.9%. Net income reached $497,000 or $0.08 per share, a notable increase from a net loss of $87,000 in Q2 2021. AMS's cash reserves also expanded to $11,967,000, providing the company with substantial resources for growth initiatives.
American Shared Hospital Services (NYSE American: AMS) will hold a quarterly conference call on August 12, 2022, to discuss its second quarter 2022 financial results. The results will be released after market close on August 11, 2022. Interested participants can join the call by dialing 1 (844) 413-3972 and accessing the webcast through the Company’s website at www.ashs.com. A replay will be available until August 19, 2022.
American Shared Hospital Services (AMS) reported a total revenue increase of 11.1% to $4,847,000 in Q1 2022, driven by a 33.2% increase in proton therapy revenue. Operating income surged to $600,000, a 567% increase, while net income reached $269,000 or $0.04 per share. Adjusted EBITDA grew by 20.1% to $1,922,000. AMS also announced a joint venture in Puebla, Mexico for a new radiation therapy facility. Cash reserves stood at $8.4 million with shareholders' equity at $24.72 million as of March 31, 2022.
American Shared Hospital Services (AMS) announced the hiring of Timothy J. Keel as Vice President of Sales and Marketing, effective May 3, 2022. Keel brings over 30 years of experience in healthcare finance, having previously worked at Dext Capital, BankAmerica, and Citibank. CEO Ray Stachowiak emphasized that Keel's expertise will enhance AMS's sales efforts. The company also mentioned a joint venture to install a linear accelerator at a radiation therapy center in Puebla, Mexico, marking its third international project.
American Shared Hospital Services (NYSE American: AMS) will host a quarterly conference call on May 12, 2022, at 3:00 PM ET to discuss its first quarter 2022 financial results. A press release detailing these results will be issued premarket on the same day. Interested parties can participate by calling 1 (844) 413-3972 or accessing a simultaneous webcast on the company's website. AMS specializes in advanced radiation therapy technologies, including Gamma Knife radiosurgery and proton therapy, positioning itself as a leader in non-invasive tumor treatments.
American Shared Hospital Services (AMS) has scheduled its Annual Meeting of Shareholders for June 21, 2022, at 8:30 a.m. PST. Due to COVID-19, the meeting will be virtual-only, prioritizing shareholder safety. Shareholders eligible to vote will be determined as of April 22, 2022. AMS specializes in providing advanced technology solutions for stereotactic radiosurgery and radiation therapy, including Gamma Knife equipment for treating brain tumors and other conditions. The press release cautions about various risks affecting the company’s growth and financial health.
American Shared Hospital Services (AMS) announces a joint venture to establish a cancer treatment facility in Puebla, Mexico, enhancing its international strategy. AMS will hold 85% ownership in the new company, responsible for upgrading a radiation therapy machine and providing advanced treatment options, including IMRT and radiosurgery. The facility aims to serve a region of over six million people, eliminating the need for long-distance travel for treatments. The facility is expected to be operational by early 2023, pending approvals.
American Shared Hospital Services (AMS) reported a strong Q4 2021, with revenue reaching $4.69 million, a 1.8% increase from Q4 2020.
Proton therapy revenue rose 20.1% to $1.68 million, while Gamma Knife revenue fell 6.3% to $3 million. Operating income was $723,000, compared to an $8.54 million loss in Q4 2020. For the full year, revenue decreased 1.2% to $17.63 million, but operating income improved significantly from a loss of $9.46 million in 2020 to a profit of $1.35 million. Cash at year-end was $8.26 million, indicating strong liquidity.